Octopus Biosafety SA (EPA:MLOCT)
France flag France · Delayed Price · Currency is EUR
0.1590
0.00 (0.00%)
Jul 30, 2026, 4:30 PM CET

Octopus Biosafety Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.050.050.230.020.070.22
Revenue Growth
-76.58%-77.19%952.01%-67.37%-70.08%-
Gross Profit
0.310.31-0.11-0.26-0.5-0.32
Operating Income
-0.84-0.84-1.44-0.73-1.12-1.4
Net Income
-0.66-0.66-1.78-0.8-1.01-0.83
Earnings Per Share
-0.04-0.04-0.12-0.20-0.25-0.21
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2024
Period EndingDec '24 Dec '24
France
0.050.05
Export
00
Unallocated
0.330.33
Total
0.390.39

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.020.020.130.060.080.69
Total Debt
0.550.550.352.71.720.47
Net Cash (Debt)
-0.52-0.52-0.23-2.64-1.650.22
Net Cash Growth
------
Net Cash Per Share
-0.04-0.04-0.02-0.65-0.410.06

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
594.04%594.04%-49.82%-1190.17%-753.97%-143.72%
Operating Margin
-1601.09%-1601.09%-627.05%-3329.84%-1676.21%-627.37%
Pretax Margin
-1603.43%-1603.43%-628.56%-3351.01%-1689.32%-631.37%
Profit Margin
-2003.12%-2003.12%-711.89%-4070.26%-2058.12%-734.48%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
52.4952.2913.5477.7547.7426.16